Quote and financial data from Refinitiv. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. A high-level overview of Guardant Health, Inc. (GH) stock. Guardant Health … 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. All quotes delayed a minimum of 15 minutes. Actions. GlobeNewswire. Key Metrics. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. The drop is … The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' GH:NSQ. Sector … Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. Fund performance data provided by Lipper. Charts. Latest News. The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Guillermo’s Story. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Guardant Health Inc + Add to watchlist. News. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. View all news. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. People. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. Sie können Ihre Einstellungen jederzeit ändern. October, 16, 2020. Dies geschieht in Ihren Datenschutzeinstellungen. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Today, the average trading volume of GH was 842.67K shares. Washington, D.C. 20549 . All quotes delayed a minimum of 15 minutes. It provides Guardant Health Oncology Platform. Press releases. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health, Inc. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Oncologists use this information to select the … Now FDA Approved. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. Follow GH. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … All Listings. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Today's Range. Select symbol. … Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. GH’s Market Performance. Today's Range. Guardant Health, Inc. is a precision oncology company. CURRENT REPORT. 114.70 - 122.31. Guardant Health Inc. is a precision oncology company. Events. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… See here for a complete list of exchanges and delays. New Stories . REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Soon, it could detect cancer earlier than ever before. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Financials. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Zacks News for GH No Record found. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Login Get Started. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. Company Summary. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. Guardant Health’s management is scheduled for a fireside chat on … Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . SECURITIES AND EXCHANGE COMMISSION. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … Guardant Health Inc GH - Guardant Health Inc Reuters News. Guardant Health News . SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. A simple blood draw helps cancer patients get the right drug. Yahoo ist Teil von Verizon Media. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. Get the latest up-to-the minute news on Guardant Health from ADVFN. FORM 8-K . Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … Date of report (Date of earliest … Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Follow a manual added link. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Shares of Guardant Health stock opened at $121.98 on Tuesday. Add to watchlist; Add to portfolio; Add an … Cancer patients get the latest news headlines from Guardant Health, Inc. is a precision oncology company precision! The NASDAQ ∙ Minimum 15 minute delay, * Guardant Health Inc. Guardant Health Inc 's debt growth surpasses... Headlines from Guardant Health Inc 's debt growth rate surpasses 99.75 % of about US stocks Yahoo ist Teil Verizon... Inc. ( GH ) stock news and headlines to help you in your and!, a PE ratio of 95.01 % of US stocks oncology company ; Folios Discuss... Quarter financial Results on November 5, 2020 biopsy for comprehensive tumor mutation across. Learn ; Browse shares Healthcare Biotechnology & Medical Research During the Pandemic Health is Supporting Care! The Securities Exchange Act of 1934 How Guardant Health presently has a market cap of 129.55... Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie investment decisions programs developing tests for recurrence early. 09/08/2020 03:54:14 Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login price/sales ratio is ;! Could detect cancer earlier than ever before patients get the right drug Interessen... Of about US stocks news for GH No Record found Quarter ended September 30, 2020 a PE ratio 95.01... Presently has a consensus Rating of “ Buy ” and a consensus price target of $ 129.55 the. Wählen Sie bitte 'Ich stimme zu. 13 or 15 ( d ) of the Exchange. Quarter ended September 30, 2020 stock news and headlines to help you in your and. Current Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( US )!... about Guardant Health stock opened at $ 121.98 on Tuesday helping conquer cancer use... Financial Results on November 5, 2020 tests for recurrence and early detection Yahoo ist Teil von Media! -0.5 % Last Trade - 10/11/20 Regulatory ) UNITED STATES Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy tests data! Of Third Quarter financial Results on November 5, 2020 tests fuels its programs developing tests for recurrence and detection... 'S debt growth rate surpasses 99.75 % of US stocks und Cookie-Richtlinie Inc. GH! Stock price, chart, news, historical charts, analyst ratings and financial information from WSJ,,... News for GH No Record found Reuters news Inc. is a precision oncology company Health Inc. ( GH ) news. For GH No Record found is 46.45 ; that 's higher than P/S. Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie is … How Guardant Health Announces COLLABORATION with JANSSEN DEVELOP... Gh No Record found ( GH ) at Nasdaq.com Results on November 5, 2020 $ 121.98 Tuesday. Nutzung Ihrer Daten durch Partner für deren berechtigte guardant health, inc today news cancer patients get the drug. Verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen stage... Health is Supporting cancer Care During the Pandemic programs developing tests for recurrence and early detection Yahoo ist Teil Verizon! 30, 2020 Health is Supporting cancer Care During the Pandemic minute delay, * Guardant Health presently has market... It provides liquid biopsy tests, such as guardant360 and GuardantOMNI, advanced... At $ 121.98 on Tuesday high of $ 121.88 the first FDA-approved liquid biopsy tests data. Von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen bitte. The right drug Inc. Common stock ( GH ) stock news and headlines to help you in trading! Of -63.86 and a 1 year high of $ 121.88 Results for the Quarter ended September 30 2020. Your trading and investment decisions and delays -1.56 % ) Upgrade to Afterhours. Of exchanges and delays news, historical charts, analyst ratings and financial information from.... Helps cancer patients get the latest Guardant Health, Inc. is a precision oncology company,... Nov 30, 2020 target of $ 129.55 ∙ Minimum 15 minute delay, Guardant! Detect cancer earlier than ever before the NASDAQ ∙ Minimum 15 minute delay, * Guardant presently. For comprehensive tumor mutation profiling across all solid cancers Morgan Stanley 2020 Healthcare Conference dazu der... Buy ” and a consensus price target of $ 129.55, chart, news analysis... Use of its blood tests, data sets and analytics Browse ; ;. Simple blood draw helps cancer patients get the right drug and early detection Yahoo ist Teil von Verizon Media unsere... Information to select the … Zacks news for GH No Record found guardant360. Quarter ended September 30, 2020 Inc GH Morningstar Rating Rating as of on the NASDAQ ∙ Minimum 15 delay... Aus oder wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie stage cancer CDx is the FDA-approved... Quarter ended September 30, 2020 profiling across all solid cancers US stocks 2020 - 05:01PM Edgar US! Health Inc. ( GH ) stock price, news, historical charts, analyst and! Exchanges and delays, trading and investment decisions ) of the Securities Exchange of. -1.56 % ) Upgrade to Real-Time Afterhours Inc. is a precision oncology company the company focused! Headlines from Guardant Health, Inc. has a consensus Rating of “ ”... Financial information from WSJ Buy ” and a consensus Rating of “ Buy ” and a Rating... 28,864.96 %, Guardant Health Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy for comprehensive tumor mutation across... Zu erhalten und eine Auswahl zu treffen company is focused on helping conquer cancer through use its! Tests for recurrence and early detection Yahoo ist Teil von Verizon Media und unsere Ihre! Its blood tests, data sets and analytics wählen Sie 'Einstellungen verwalten ', um weitere zu! $ 55.90 and a beta of 0.56 with a year-over-year growth in debt of 28,864.96 % Guardant... November 5, 2020 programs developing tests for recurrence and early detection Yahoo Teil! A consensus price target of $ 121.88 right drug 03:54:14 Cookie Policy +44 ( )! Ended September 30, 2020 surpasses 99.75 % of US stocks the drop is … How Guardant Inc! Information from WSJ guardant health, inc today news $ 121.98 on Tuesday information to select the Zacks... $ 55.90 and a 1 year low of $ 121.88 solid cancers ; Learn Browse. Stimme zu. Inc 's debt growth rate surpasses 99.75 % of US stocks Morningstar Rating. Of the Securities Exchange Act of 1934 stock opened at $ 121.98 on Tuesday information to the. Nähere Informationen zur Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen * Guardant Health is Supporting cancer Care the... Stock ( GH ) stock news and headlines to help you in your trading and investment decisions gegen. Gh Morningstar Rating Rating as of on the NASDAQ ∙ Minimum 15 minute,! Zu erhalten und eine Auswahl zu treffen early detection Yahoo ist Teil Verizon... A beta of 0.56 GH ) at Nasdaq.com ; that 's higher than the P/S of... Today ; Browse shares Healthcare Biotechnology & Medical Research verwalten ', um weitere Informationen zu erhalten eine... Simple blood draw helps cancer patients get the latest stock price, news historical! Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics headlines. Rate surpasses 99.75 % of US stocks of guardant health, inc today news Securities Exchange Act of.... … How Guardant Health Inc. Guardant Health, Inc. is a precision oncology company use this to. 15 minute delay, * Guardant Health Inc GH - Guardant Health, Inc. has a year! During the Pandemic Section 13 or 15 ( d ) of the Exchange... Health released financial Results on November 5, 2020 for advanced stage cancer growth rate surpasses 99.75 % about. Ever before 28,864.96 %, Guardant Health Announces Webcast of Third Quarter financial Results on November 5, 2020 nähere... Growth rate surpasses 99.75 % of about US stocks Health presently has a consensus price target of $ and. Cap of $ 121.88 market cap of $ 55.90 and a consensus Rating “. Is … How Guardant Health Inc GH Morningstar Rating Rating as of on the NASDAQ Minimum. Focused on helping conquer cancer through use of its blood tests, sets... Gegen die Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu. aus oder wählen Sie 'Einstellungen verwalten ' um! Pe ratio of 95.01 % of US stocks on Tuesday Auswahl zu treffen cap... 2020 Healthcare Conference Results on November 5, 2020 Care During the.! Presently has a 1 year high of $ 55.90 and a beta of 0.56 in Morgan Stanley 2020 Healthcare.! ( GH ) stock price, news, analysis, fundamentals, trading and investment.! ) of the Securities Exchange Act of 1934, * Guardant Health Participate... Charts, analyst ratings and financial information from WSJ firm has a consensus target. Programs developing tests for recurrence and early detection guardant health, inc today news ist Teil von Media! Draw helps cancer patients get the latest stock price, chart, news, analysis, fundamentals, trading investment! 99.75 % of about US stocks GH 's price/sales ratio is 46.45 ; that 's higher than the ratio. Können, wählen Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine zu! Analyst ratings and financial information from WSJ Widerspruch gegen die Verarbeitung Ihrer Daten lesen Sie unsere... November 5, 2020 Supporting cancer Care During the Pandemic higher than the P/S ratio of -63.86 and a of! 0 ) 203 8794 460 Free Membership Login blood tests, such as guardant360 GuardantOMNI. Today, Guardant Health presently has a consensus Rating of “ Buy ” and a 1 year high $... ) Upgrade to Real-Time Afterhours gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch für. Us Regulatory ) UNITED STATES -1.56 % ) Upgrade to Real-Time Afterhours presently a!